Inactive Instrument
Capstone Therapeutics Corp Share Price Other OTC
Stocks
US14068E1091
Construction Materials
| Market Cap | 31.36L 27.52L 25.63L 23.57L 44.19L 30Cr 44.95L 3.04Cr 1.19Cr 15Cr 1.18Cr 1.15Cr 51Cr | P/E 2026 * |
1.24x | P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 31.36L 27.52L 25.63L 23.57L 44.19L 30Cr 44.95L 3.04Cr 1.19Cr 15Cr 1.18Cr 1.15Cr 51Cr | EV / Sales 2026 * |
0.04x | EV / Sales 2027 * | - |
| Free-Float |
57.16% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | +11.54% |
| Manager | Title | Age | Since |
|---|---|---|---|
Matthew Lipman
CEO | Chief Executive Officer | 47 | 02/12/2024 |
Edward Schultz
DFI | Director of Finance/CFO | 42 | 25/08/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Jock Holliman
CHM | Chairman | 73 | 05/04/2006 |
Michael Toporek
CHM | Chairman | 62 | - |
Matthew Lipman
BRD | Director/Board Member | 47 | 14/07/2017 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +11.54% | -.--% | - | - | 31.36L | ||
| -1.61% | -7.58% | +301.32% | +237.19% | 178.38Cr | ||
| +2.68% | +2.71% | +26.85% | +108.18% | 143.14Cr | ||
| +0.26% | -5.32% | -16.13% | +18.15% | 93Cr | ||
| +3.64% | 0.00% | -8.80% | -30.91% | 55Cr | ||
| +0.74% | +6.27% | -22.35% | -23.88% | 40Cr | ||
| +1.93% | -0.49% | +18.14% | +40.63% | 22Cr | ||
| +2.81% | +1.93% | +9.57% | -4.23% | 19Cr | ||
| -1.39% | -3.57% | - | - | 18Cr | ||
| +3.73% | -4.58% | +81.16% | +362.96% | 15Cr | ||
| Average | +2.43% | -2.10% | +48.72% | +88.51% | 64.97Cr | |
| Weighted average by Cap. | +0.83% | -2.06% | +99.71% | +111.50% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 7.21Cr 6.33Cr 5.89Cr 5.42Cr 10Cr 688.93Cr 10Cr 70Cr 27Cr 341.66Cr 27Cr 26Cr 1.18TCr | - |
| Net income | 23.52L 20.64L 19.22L 17.68L 33.14L 22Cr 33.71L 2.28Cr 89.26L 11Cr 88.3L 86.39L 39Cr | - |
| Net Debt | - | - |
Employees
-
Sector
Construction Materials
















